Industry
GLP-1 Medications Show Potential to Treat Addiction, Emerging Research Suggests
Emerging research indicates that GLP-1 medications, widely used for obesity and diabetes treatment, may help treat addiction disorders. The studies add to a growing list of unanticipated effects associated with this drug class. The findings are preliminary and do not yet reflect approved indications or clinical practice guidelines. If further research confirms these effects and leads to FDA approval for addiction treatment, Medicaid programs could face coverage decisions for a new high-cost indication with significant budget implications.
Why it mattersMedicaid programs cover GLP-1s for diabetes and, in some states, obesity — a potential new addiction treatment indication could expand utilization and state spending substantially.